Trials of AIDS vaccine to start in Switzerland and United Kingdom
BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7396.952/d (Published 03 May 2003) Cite this as: BMJ 2003;326:952
- Fiona Fleck
- Geneva
Clinical trials of a new vaccine against HIV, which has infected more than 40 million people worldwide, start in Switzerland and the United Kingdom in June.
Dr Jean-Pierre Kraehenbuhl, vice president of EuroVacc, the foundation organising the trials, said two vaccines would be tested: DNA-C, developed by Professor Hans Wolf of the University of Regensburg, Germany, and its booster, NYVAC, developed by the French pharmaceutical company Aventis.
Dr Kraehenbuhl said that about 160 healthy volunteers—half in London and half in the Swiss city of Lausanne, where EuroVacc is based—will test the vaccine …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.